+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Electroceuticals: Technologies and Global Markets

  • ID: 4856641
  • Report
  • November 2019
  • Region: Global
  • 129 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Biotronik Inc.
  • Cochlear Corp.
  • Getinge Ab
  • Livanova Plc
  • Nevro Corp.
  • MORE

Report Scope:

This report provides a comprehensive summary of electroceutical technologies and global markets, along with detailed profiles of key market players, a revenue product portfolio and recent activities. This report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. This report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. This study segments the market on the basis of applications and end use. Geographic market analysis is provided for all major segments.

The Report Includes:

  • 29 data tables and 24 additional tables
  • An overview of global markets and technologies for electroceuticals
  • Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Discussion on why electroceuticals are considered as an alternative to drug-based remedies
  • Identification of endogenous and exogenous factors that are impacting the global market growth
  • Coverage of several diseases such as epilepsy, cardiovascular diseases, rheumatoid arthritis and diabetes and their treatment using electroceuticals
  • Information on RecoveryRx medical device, which is used for the treatment of postoperative pain of opioid/NSAID therapy
  • Comprehensive profiles of leading companies in the industry, including Abbott Laboratories Inc., Biotronik Inc., Cochlear Corp., GlaxoSmithKline Plc and Sonova AG
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Biotronik Inc.
  • Cochlear Corp.
  • Getinge Ab
  • Livanova Plc
  • Nevro Corp.
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Market Definition
  • North America
  • Cardioverter Defibrillators and Cardiac Pacemaker Segment
  • R&D
  • Public Access Defibrillators (PAD)
  • Asia Pacific
  • Battery Technology
  • Factors Driving Market Growth
  • CVD
  • Product Launch
  • Growing Geriatric Population
  • Factors Restraining Market Growth
  • Alternative Drugs: Treatment of Arrhythmia
  • Stringent Government Regulations
  • Hackable Pacemakers
  • Low Awareness
  • Opportunities
  • Growing Healthcare Expenditures

Chapter 4 Market Breakdown by Technology Type

  • Cardioverter Defibrillators and Cardiac Pacemakers
  • Deep Brain Stimulators (DBS)
  • Spinal Cord Stimulators (SCS)
  • Vagus Nerve Stimulators
  • Hearing Aids and Cochlear Implants
  • Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)

Chapter 5 Market Breakdown by End User

  • Hospitals and Clinics
  • Homecare and Others

Chapter 6 Market Breakdown by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Rest of The World
  • Latin America
  • The Middle East and Africa

Chapter 7 Patent Review/New Developments

Chapter 8 Analysis of Market Opportunities

  • Key Manufacturers
  • Key Players
  • Abbott Laboratories Inc.
  • Boston Scientific Corp.
  • Demant A/S
  • Medtronic PLC
  • Sonova Holding AG
  • Premarket Approval (PMA) Of Electroceuticals

Chapter 9 Company Profiles

  • Abbott Laboratories Inc.
  • Advanced Bionics Ag
  • Aleva Neurotherapeutics Sa
  • Axonics Modulation Technologies Inc.
  • Bioelectronics Corp.
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cala Health Inc.
  • Cochlear Corp.
  • Demant A/S
  • Edwards Lifesciences Corp.
  • Electrocore Inc.
  • Functional Neuromodulation Ltd.
  • Glaxosmithkline Plc
  • Getinge Ab
  • Gn Store Nord
  • Hangzhou Nurotron Biotechnology Co. Ltd.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Livanova Plc
  • Medtronic Plc
  • Neuropace, Inc.
  • Nevro Corp.
  • Nuvectra Corp.
  • Second Sight Medical Products Inc.
  • Sivantos Pte. Ltd.
  • Sonova Ag
  • Starkey Hearing Technologies
  • Stimwave Llc
  • Terumo Corp.
  • Zoll Medical Corp.

List of Tables
Summary Table: Global Market for Electroceuticals, by Product, Through 2024
Table 1: Medications for Heart Dysfunction
Table 2: Global Market for Electroceuticals, by Product, Through 2024
Table 3: Global Market for Cardioverter Defibrillators and Cardiac Pacemaker, by Region, Through 2024
Table 4: Global Market for Cardioverter Defibrillators and Cardiac Pacemakers, by Product, Through 2024
Table 5: U.S. FDA Product Classification: Defibrillators
Table 6: U.S. FDA Pacemaker Product Classification
Table 7: Global Market for Deep Brain Stimulators, by Region, Through 2024
Table 8: U.S. FDA Neurostimulator Product Classification, 2019
Table 9: Global Market for Spinal Cord Stimulators, by Region, Through 2024
Table 10: Global Market for Vagus Nerve Stimulators, by Region, Through 2024
Table 11: Global Market for Hearing Aids and Cochlear Implants, by Region, Through 2024
Table 12: Global Market for Hearing Aids and Cochlear Implants, by Product, Through 2024
Table 13: U.S. FDA Cochlear Implant Product Classification
Table 14: Global Market for Other Products, by Region, Through 2024
Table 15: Global Market for Electroceuticals, by End User, Through 2024
Table 16: Global Market for Hospitals and Clinics, by Region, Through 2024
Table 17: Hospitals with Notable Services
Table 18: Global Market for Homecare and Others, by Region, Through 2024
Table 19: Cardiac Devices
Table 20: Global Market for Electroceuticals, by Region, Through 2024
Table 21: North American Market for Electroceuticals, by Country, Through 2024
Table 22: North American Market for Electroceuticals, by Product, Through 2024
Table 23: North American Market for Electroceuticals, by End User, Through 2024
Table 24: European Market for Electroceuticals, by Country, Through 2024
Table 25: European Market for Electroceuticals, by Product, Through 2024
Table 26: European Market for Electroceuticals, by End User, Through 2024
Table 27: European Reimbursement
Table 28: CE Mark Approval: Electroceuticals Devices
Table 29: Heart Disease Statistics, UK, 2016
Table 30: Asia-Pacific Market for Electroceuticals, by Country, Through 2024
Table 31: Asia-Pacific Market for Electroceuticals, by Product, Through 2024
Table 32: Asia-Pacific Market for Electroceuticals, by End User, Through 2024
Table 33: China’s Medical Device Regulations
Table 34: Medical Devices Approved in Japan, FY 2018 and FY 2019
Table 35: Rest of The World Market for Electroceuticals, by Product, Through 2024
Table 36: Rest of The World Market for Electroceuticals, by End User, Through 2024
Table 37: New Products and Technologies
Table 38: Patents by Category, Jan. 2017-Aug. 2019
Table 39: Patents by Key Players, Jan. 2017-Aug. 2019
Table 40: Notable Patents: U.S., Jan. 2017-Aug. 2018
Table 41: Notable Patents: Europe, Jan. 2017-Aug. 2018
Table 42: Notable Patents: Japan, Jan. 2017-Aug. 2018
Table 43: Abbott Laboratories Inc. Divisions, 2018
Table 44: Boston Scientific Corp.: Products and Models
Table 45: Demant’s Hearing Solutions
Table 46: Demant’s R&D Expenses, 2017 and 2018
Table 47: Medtronic Plc: R&D Expenses, 2017 and 2018
Table 48: Sonova Holding AG: Segments and Brands
Table 49: U.S. FDA PMA for Defibrillators, Jan. 2019-July 2019
Table 50: U.S. FDA PMA for Pacemakers, Jan. 2019-July 2019
Table 51: U.S. FDA PMA for Cochlear Implants, Jan. 2019-July 2019
Table 52: U.S. FDA PMA for Neuro Stimulators, Jan. 2019-July 2019

List of Figures
Summary Figure: Global Market for Electroceuticals, by Product, 2018-2024
Figure 1: Fatalities from CVD: U.S., 2017
Figure 2: Projected Global Population, Aged 60 and Above, 1990-2100
Figure 3: Defibrillator Awareness: U.S., 2017
Figure 4: Healthcare Expenditure: U.S., 1970-2017
Figure 5: Healthcare Expenditure Per Capita: Asia Pacific, 2010 and 2016
Figure 6: Pacemakers
Figure 7: Global Incidence of Parkinson’s Disease, 2013-2017
Figure 8: Spinal Cord Stimulator: Parts/Functions
Figure 9: Global Incidence of Epilepsy, 2013-2017
Figure 10: Hearing Impairment Stages
Figure 11: Global Prevalence of Age-Related and Other Hearing Loss, 2013-2017
Figure 12: European Medical Device Market Based on Manufacturer Prices, by Country, 2017
Figure 13: Hearing Loss Prevalence in UK, 2009-2018
Figure 14: Anovum under European Hearing Instrument Manufacturers Association
Figure 15: Incidence of Parkinson’s Disease, Germany, 2013-2017
Figure 16: Ischemic Heart Disease, 2012-2017
Figure 17: China’s Age-Related and Other Hearing Loss
Figure 18: Indian Medical Device Market, by Segment, 2016
Figure 19: India’s Ischemic Heart Disease
Figure 20: Japan’s Ischemic Heart Disease
Figure 21: Age-Related and Other Hearing Loss, 2012-2017
Figure 22: Middle East’s Prevalence of Various Diseases, 2017
Figure 23: Abbott Laboratories Inc.: Strategic Priorities
Figure 24: Demant: Global Revenue, by Region, 2018
Figure 25: Demant: Global Revenue, by Market Segment, 2018
Figure 26: Medtronic: Global Revenue Share, by Segment, 2017
Figure 27: Sonova Holding AG: Competitive Strengths

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Biotronik Inc.
  • Cochlear Corp.
  • Getinge Ab
  • Livanova Plc
  • Nevro Corp.
  • MORE

Electroceuticals are medical devices that are used to restore health in patients. Patients may hold these devices against the skin orthe devices may be implanted. Also known as bioelectric medicine, these devices offer an alternative to drug-based remedies. Most of the time, this is not the first line of treatment. The devices are often used only when health cannot be restored with drugs. Most electroceuticals do not cure conditions. However, these devices can reduce pain and bypass affected parts of the body.

Electroceuticals function through neurostimulation and modulation of the nervous systems through electrical impulses. Electroceutical devices are used in several ailments and disorders related to neurology and cardiology. The devices are effective in treating these conditions through invasive and non-invasive methods.

The global electroceuticals market is expected to grow significantly due to various factors: rising incidence and prevalence of chronic diseases, growing investment into the development of advanced electroceuticals and government backing. For instance, GSK PLC and Microsoft Corp. invested significantly into the R&D of advanced electroceutical devices. In 2016, the companies collaborated to form Galvani Bioelectronics, planning to invest $715 million over the next seven years into R&D programs. Around 55% of the stake is owned by GSK PLC, 45% by Microsoft Corp.

A growing geriatric population is another major factor that is expected to surge market growth during the forecast period. The elderly population is at an increased risk of developing various diseases: Parkinson's, Alzheimer's, cardiac arrhythmias and epilepsy. Per the World Bank, around 9.0% of the global population is geriatric with an increased risk of neurological disease. According to the Alzheimer’s Association, in 2019, around 5.8 million Americans of all ages are living with Alzheimer’s dementia. Out of this 5.8 million, 5.6 million were age 65+.

Significant investment in the electroceuticals industry is another major factor creating considerable opportunity in the global electroceuticals market. Medtronic PLC, Boston Scientific, Biotronik, Cochlear Ltd., Demant A/S and GlaxoSmithKline PLC have been spending significantly on R&D programs related to the advance electroceutical devices. In 2016, NIH announced a fund of $248 million that was distributed to public and private research communities through Stimulating Peripheral Activity to Relieve Conditions (SPARC) to develop future electroceuticals. Such a huge amount of funding activity in the electroceuticals industry will boost the growth of the market in the near future.

Increasing prevalence of medical conditions such as neurological disorders (epilepsy, Parkinson’s, paraneoplastic neurologic syndrome, migraines and much more) results in increased R&D for the development of electroceuticals. Per the Institute for Health Metrics and Evaluation, around 10 million people were living with Parkinson’s disease in 2019, globally. Every year more than a million new cases of Parkinson’s disease are registered, globally. There are more than 1.3 billion people living with hearing loss, across the globe, which is expected to drive the hearing aid and cochlear implant market.

Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories Inc.
  • Advanced Bionics Ag
  • Aleva Neurotherapeutics Sa
  • Axonics Modulation Technologies Inc.
  • Bioelectronics Corp.
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cala Health Inc.
  • Cochlear Corp.
  • Demant A/S
  • Edwards Lifesciences Corp.
  • Electrocore Inc.
  • Functional Neuromodulation Ltd.
  • Getinge Ab
  • Glaxosmithkline Plc
  • GN Store Nord
  • Hangzhou Nurotron Biotechnology Co. Ltd.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Livanova Plc
  • Medtronic PLC
  • Neuropace, Inc.
  • Nevro Corp.
  • Nuvectra Corp.
  • Premarket Approval (PMA) Of Electroceuticals
  • Second Sight Medical Products Inc.
  • Sivantos Pte. Ltd.
  • Sonova Holding AG
  • Starkey Hearing Technologies
  • Stimwave Llc
  • Terumo Corp.
  • Zoll Medical Corp.
Note: Product cover images may vary from those shown
Adroll
adroll